Participation in a patient support group increases prostate cancer patient knowledge

A newly published study from a group of German researchers examined the degree to which participation in patient support group activities increased prostate cancer patients’ health literacy and, specifically, their prostate cancer‐specific and non‐cancer‐specific knowledge about health care. … READ MORE …

Common long-term side effects of ADT in treatment of prostate cancer

A new analysis of data from men treated for their prostate cancer between 1992 and 2009 has provided additional information with respect to risks for long-term side effects of androgen deprivation therapy (ADT). … READ MORE …

Should we be screening for prostate cancer among African Americans?

In a new lecture on the UroToday web site, Dr. Judd Moul of Duke University presents a passionate plea for better data on the relevance of PSA-based screening for risk of prostate cancer among African Americans. … READ MORE …

When is a metastasis really metastatic today?

There is an interesting editorial commentary by Dr. Daniel George that was published just over a week ago on the UroToday web site. … READ MORE …

ORP vs. RALP re-visited

A newly published report in The Lancet Oncology has pretty much finally confirmed what many of us have been assuming for a long time now: … READ MORE …

Speed of change in the management of prostate cancer

One of our regular correspondents (who lives in England) was recently told something rather interesting by the Consultant Urologist he sees in the UK. … READ MORE …

Active surveillance in management of younger men with prostate cancer

Your sitemaster has long argued that it is perfectly reasonable for many younger men diagnosed with low- and very low-risk forms of prostate cancer to be managed initially on active surveillance (despite reticence on the parts of many physicians and many patients). … READ MORE …